Recent Finacing
Recent Raise
Perosphere develops a Phase II reversal agent for novel oral anticoagulants, ultra-rapid insulin lispro, repurposed felbamate, and peanut desensitization, and is building a 12,000 sq ft lab/manufacturing HQ.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor